Literature DB >> 17173877

The superficial layers of the superior colliculus are cytoarchitectually and myeloarchitectually disorganized in the reelin-deficient mouse, reeler.

Kousuke Baba1, Shunsuke Sakakibara, Tomiyoshi Setsu, Toshio Terashima.   

Abstract

The causative gene for the reeler mouse is reelin which encodes Reelin protein, an extracellular molecule. In the present study, we have examined the cytoarchitecture, myeloarchitecture, and afferent/efferent systems of the superior colliculus (SC) of the reeler mouse. In the reeler, the laminar structures of the superficial three layers of the SC were disorganized and intermingled into a single layer, i.e., the superficial fused layer (SuF), as previously reported in the reelin-deficient SRK rat (Sakakibara et al., Develop. Brain Res. 141:1-13). Next, we have investigated the course and terminals of visual corticotectal and retinotectal projections with an injection of biocytin into the visual cortex or an injection of cholera toxin subunit B into the retina, respectively. In the reeler, anterogradely labeled visual corticotectal and retinotectal fibers took an aberrant course within the SuF, resulting in abnormal myeloarchitecture of the superficial SC of the reeler. Retrograde labeling of tectospinal tract neurons could not show any differences between the normal and reeler mice, suggesting that the deep layers of the reeler SC are cytoarchitectually normal. In situ hybridization and immunohistochemical studies have shown that reelin mRNA and Reelin protein were both recognized in the normal SC. These results suggest that Reelin protein plays some roles in histogenesis of the superficial layers of the SC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17173877     DOI: 10.1016/j.brainres.2006.09.113

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

Review 1.  Molecular and cellular mechanisms of lamina-specific axon targeting.

Authors:  Andrew D Huberman; Thomas R Clandinin; Herwig Baier
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03       Impact factor: 10.005

2.  Reelin is required for class-specific retinogeniculate targeting.

Authors:  Jianmin Su; Cheryl V Haner; Terence E Imbery; Justin M Brooks; Duncan R Morhardt; Karen Gorse; William Guido; Michael A Fox
Journal:  J Neurosci       Date:  2011-01-12       Impact factor: 6.167

3.  Cytoarchitectural disruption of the superior colliculus and an enlarged acoustic startle response in the Tuba1a mutant mouse.

Authors:  A Edwards; C D Treiber; M Breuss; R Pidsley; G-J Huang; J Cleak; P L Oliver; J Flint; D A Keays
Journal:  Neuroscience       Date:  2011-08-22       Impact factor: 3.590

4.  The disorganized visual cortex in reelin-deficient mice is functional and allows for enhanced plasticity.

Authors:  Justyna Pielecka-Fortuna; Robin Jan Wagener; Ann-Kristin Martens; Bianka Goetze; Karl-Friedrich Schmidt; Jochen F Staiger; Siegrid Löwel
Journal:  Brain Struct Funct       Date:  2014-08-15       Impact factor: 3.270

Review 5.  The Reeler Mouse: A Translational Model of Human Neurological Conditions, or Simply a Good Tool for Better Understanding Neurodevelopment?

Authors:  Laura Lossi; Claudia Castagna; Alberto Granato; Adalberto Merighi
Journal:  J Clin Med       Date:  2019-12-01       Impact factor: 4.241

6.  Asymmetric N-cadherin expression results in synapse dysfunction, synapse elimination, and axon retraction in cultured mouse neurons.

Authors:  Kim N Pielarski; Bernd van Stegen; Aksana Andreyeva; Katja Nieweg; Kay Jüngling; Christoph Redies; Kurt Gottmann
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

7.  Identification of genes differentially expressed in dorsal and ventral chick midbrain during early development.

Authors:  A Chittka; Jn Volff; A Wizenmann
Journal:  BMC Dev Biol       Date:  2009-04-27       Impact factor: 1.978

Review 8.  From mice to men: lessons from mutant ataxic mice.

Authors:  Jan Cendelin
Journal:  Cerebellum Ataxias       Date:  2014-06-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.